麻豆社

麻豆社.CA / The Neuro / About

Stories and News at The Neuro

Explore inspiring stories of how The Neuro integrates patient care with Open Science research and training, key to advancing science and medicine.

First-in-Canada RNA trial for rare ataxia launches at The Neuro

10 Mar 2025

This potential new treatment hopes to block the faulty gene which causes Spinocerebellar ataxia type 2, a degenerative disease that is overrepresented in Quebec.

Improving quality of life through research at the Azrieli Neurodevelopment Clinic

4 Mar 2025

Dr. Gabriella Gobbi works closely with families, teachers, and caregivers to develop strategies that help improve quality of life, offering medical and therapeutic options for a meaningful relief.听

Getting an EEG at The Neuro

25 Feb 2025

鈥淥ur goal was to create a resource that helps participants feel at ease before they even walk through the door. These videos offer a familiarization tool that can make the experience more...

Getting an MRI at The Neuro

24 Feb 2025

Visiting a hospital or research center can bring up a lot of questions鈥擶hat will it look like? Who will I meet? What will happen?...

The Neuro-Patient Resource Centre wants to hear from you!

4 Feb 2025

Your input is valuable, and by participating in this survey, you can help shape important decisions that impact the Neuro-Patient Resource Centre, and have a chance share your ideas.听听...

January is Alzheimer鈥檚 Awareness Month in Canada

17 Jan 2025

To mark this month, the Neuro-Patient Resource Centre has developed a reading list on Alzheimer鈥檚 disease available in their collection.听

Pages

Subscribe to Articles RSS

News Releases

View more newsRSS feed icon

The Neuro logo听麻豆社 logo

听

The Neuro (Montreal Neurological Institute-Hospital)听is a bilingual academic healthcare institution. We are a听麻豆社 research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the 麻豆社 Health Centre.听We are听proud to be a Killam Institution, supported by the Killam Trusts.

听

听

Back to top